Rhoen-Klinikum AG
RHKJF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.57 | -3.57 | -0.64 | 0.31 |
| FCF Yield | 0.00% | 0.00% | 0.00% | 0.00% |
| EV / EBITDA | 25.48 | 28.06 | 26.53 | 18.17 |
| Quality | ||||
| ROIC | 0.65% | 0.45% | 0.43% | 0.92% |
| Gross Margin | 1.11% | -0.43% | 66.17% | 41.34% |
| Cash Conversion Ratio | – | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | 4.74% | 4.17% | 5.08% | 6.27% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | -8.63 | -7.24 | -10.65 | -3.41 |
| Interest Coverage | 12.77 | 11.71 | 9.13 | 19.84 |
| Efficiency | ||||
| Inventory Turnover | 11.90 | 11.76 | 4.12 | 6.65 |
| Cash Conversion Cycle | 50.34 | 53.41 | 31.72 | 78.58 |